Previous 1 2 3 4 5 Next
Cell separation is key to sexed semen technology Farmers Weekly
Sexed semen is heading for the pig industry, thanks to a new semen sorting technology developed in Wales. Ovasort, a Welsh start-up company has signed an exclusive global licensing deal with Dansk Svineproduktion (Danish Bacon) to provide new semen sexing technology. (Fri, 15 Sep 2006 14:42:39 GMT)
News in brief from Philadelphia
PHILADELPHIA - The historic Reading Terminal Market will try opening from 9 a.m. to 4 p.m. on Sundays starting Oct. 15, the market announced Thursday. (Fri, 15 Sep 2006 14:45:40 GMT)
Researchers Image Molecular Motor Structural Changes
An international team of researchers has shed new light on how tiny molecular motors that transport materials within cells generate the energy that powers their movements. (Fri, 15 Sep 2006 16:05:44 GMT)
Distinct Genetic Profiles Found For Northern, Southern Europeans
An international team of scientists lead by researchers at the University of California, Davis, Health System has found that, with respect to genetics, modern Europeans fall into two groups: a Northern group and a Southern, or Mediterranean one. The findings are important because they provide a method for scientists to take into account European ancestry when looking for genes involved in (Fri, 15 Sep 2006 16:05:57 GMT)
New study pinpoints unique genetic susceptibility for viral encephalitis
The study is being published September 14 in Science X-Press, an advanced, online edition of the journal Science. (Fri, 15 Sep 2006 16:58:27 GMT)
External RNA Controls Consortium Names Testing Sites for Initial Phase of RNA Control Testing
SANTA CLARA, Calif.----Sept. 15, 2006--The External RNA Controls Consortium announced today that eight testing sites have registered for the initial phase of the RNA control testing. (Fri, 15 Sep 2006 17:59:00 GMT)
The Entrepreneur Center to Host Pavilion at NBC4 Connected Expo
Seventeen start-up companies based in the Greater Washington area and representing a wide range of technology innovation in the region will demo their products to consumers at The Entrepreneur Center Pavilion at the NBC4 Connected Expo this weekend -- Sept. 16 - 17 -- at the Washington Convention Center. (Fri, 15 Sep 2006 18:29:00 GMT)
What's Really Propping Up The Economy
If you really want to understand what makes the U.S. economy tick these days, don't go to Silicon Valley, Wall Street, or Washington. Just take a short trip to your local hospital. Park where you don't block the ambulances, and watch the unending flow of doctors, nurses, technicians, and support personnel. You'll have a front-row seat at the health-care economy. (Fri, 15 Sep 2006 20:00:02 GMT)
SA defends planned GM crop ban extension
The South Australian Government has defended its plan to extend a moratorium on growing genetically modified (GM) crops, saying it has benefits in the global market. (Fri, 15 Sep 2006 21:20:00 GMT)
In Business Q and A
Sitting in an elegant conference room with art chosen for its healing properties — like all the pieces throughout the Nevada Cancer Institute research building — Heather Murren talks about how the project is poised to become a standout in the national research scene. (Fri, 15 Sep 2006 22:06:22 GMT)
The Entrepreneur Center to Host Pavilion at NBC4 Connected Expo
at the Washington Convention Center. (Fri, 15 Sep 2006 23:14:23 GMT)
The Entrepreneur Center to Host Pavilion at NBC4 Connected Expo
at the Washington Convention Center. (Sat, 16 Sep 2006 00:45:03 GMT)
Unexpected Effect Of Direct-to-consumer Drug Ads
Television ads for prescription drugs are everywhere, enticing people to ask their doctors for this drug or that one, but the effect this type of ad has on American healthcare may be more complicated than simply inducing patients to choose one brand or the other, according to a team of researchers. [click link for full article] (Sat, 16 Sep 2006 01:09:57 GMT)
High-throughput Oncogene Mutation Detection In Human Cancers By Mass Spectrometry-based Genotyping
Researchers have devised a new method to detect a spectrum of known gene mutations in a variety of cancer genes that they say is both sensitive and cost-effective. They say that if validated, this method of genotyping might ultimately be used in "real time" to match patients to available targeted therapies. [click link for full article] (Sat, 16 Sep 2006 05:10:07 GMT)
Prtotection For Nerve Cells - Eating Up Defective Proteins
Nerve cells in the Central Nervous System can defend against and recover from damage by proteinlike clusters which are associated with neurodegenerative diseases such as Huntington`s Chorea. The neurons are able to eat up and digest defective proteins by specialized processes within each cell. Dr. Ron R. [click link for full article] (Sat, 16 Sep 2006 07:11:38 GMT)
Shorter Distance On Six-minute Walk Test Points Up A Greater Risk Of Death
For idiopathic pulmonary fibrosis patients awaiting lung transplantation, a simple walk test can predict mortality rates. A new study found that individuals with IPF who cover less than 680 feet during the six-minute test are four times more likely to die than those who can walk greater distances. (Sat, 16 Sep 2006 10:04:17 GMT)
Rodent's Bizarre Traits Deepen Mystery Of Genetics, Evolution
A shadowy rodent has potential to shed light on human genetics and the mysteries of evolution. Purdue University research has shown that the vole, a mouselike rodent, is not only the fastest evolving mammal, but also harbors a number of puzzling genetic traits that challenge current scientific understanding. (Sat, 16 Sep 2006 10:04:39 GMT)
Purdue dedicates building to promote high-tech research
West Lafayette -- Purdue University dedicated a new computer science building Friday, a 100,000-square-foot complex equipped with high-tech equipment that school officials said would push the boundaries of science. (Sat, 16 Sep 2006 10:04:52 GMT)
Craig Mello Named Winner Of The Dr. Paul Janssen Award For Biomedical Research
Johnson & Johnson today announced that Craig C. Mello, Ph. D., a professor of Molecular Medicine at the University of Massachusetts Medical School, Worcester, MA, and an investigator at the Howard Hughes Medical Institute, has been named the inaugural recipient of The Dr. Paul Janssen Award for Biomedical Research. Dr. [click link for full article] (Sat, 16 Sep 2006 14:10:07 GMT)
Gaps in our history books
HISTORY is no longer a career of choice among young college students. A cursory check on enrollments in four of the biggest universities in Metro Manila showed that there were even fewer majors in history than in physical education. (Sat, 16 Sep 2006 14:16:05 GMT)
Gene Signature Assesses Breast Cancer Outcomes
A test that looks at the expression of 70 genes linked to breast cancer can accurately assess a patient's risk of recurrence or death, according to an article in the Sept. 6 issue of the Journal of the National Cancer Institute. (Sat, 16 Sep 2006 22:21:11 GMT)
Technovators TR-iumph
India-connect: Born to Keralite parents settled in the US. Patents and papers: Has five patents awarded or pending. Published more than 16 papers. TR-iumph factor: As a TR35, Maliakal continues the trend of at least one Bell Labs scientist being named annually in the list. (Sun, 17 Sep 2006 00:13:38 GMT)
Genomics And Cancer 2006, September 13-16, 2006 -Conference Report III: Cancer And Infections - Are There Common
Researchers in Italy have demonstrated how Helicobacter pylori triggers the first step of cancer development in cells of the gastric mucosa. Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) are investigating a key molecule in the development of cancer, infection and inflammation. [click link for full article] (Sun, 17 Sep 2006 07:11:09 GMT)
National Institutes Of Health To Map Genomic Changes Of Lung, Brain And Ovarian Cancers
The National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), both part of the National Institutes of Health (NIH), today announced the first three cancers that will be studied in the pilot phase of The Cancer Genome Atlas (TCGA) project. The cancers to be studied in the TCGA Pilot Project are lung, brain (glioblastoma), and ovarian. [click link for full article] (Sun, 17 Sep 2006 08:09:57 GMT)
College's move to Phoenix in limbo
Time constraints, coupled with a lack of money, have killed a plan to locate the Walter Cronkite School of Journalism in a signature high-rise development in downtown Phoenix. (Sun, 17 Sep 2006 08:41:14 GMT)
International genome scientists and clinicians met in Berlin (09/17/2006)
Around 200 scientists from Europe, Japan and North America took part in the first international conference on the topic of ‘Neurodegenerative Diseases: Molecular Mechanisms in a Functional Genomics Framework’, which took place in Berlin from 6-9 September 2006. The genome researchers and clinicians discussed the recent findings as to the causes of such neurodegenerative diseases as Alzheimer’s, (Sun, 17 Sep 2006 09:35:14 GMT)
Architects Of The Envelope: Scientists Discover An Essential Nucleus-building Protein
Every time a cell divides, the protective envelope that surrounds the nucleus is broken down and rebuilt into two new ones. Envelopes are highly complex structures of membranes and proteins which must be precisely reassembled for the nuclei to function. Scientists at the IRB in Barcelona, the EMBL and the Pasteur Institute have discovered a protein that plays a crucial role in the assembly and (Sun, 17 Sep 2006 16:04:29 GMT)
Modeling The Movement Of Electrons At The Molecular Scale
Marshall Newton, a theoretical chemist at the U.S. Department of Energy's Brookhaven National Laboratory will give a talk about the theoretical techniques used to understand the factors affecting electron transfer at the 232nd national meeting of the American Chemical Society. The talk will be held at 3:30 p.m. Pacific Time on Monday, September 11, 2006, at the Grand Hyatt San Francisco. (Sun, 17 Sep 2006 16:05:34 GMT)
What's Next For Gene Therapy? Plastics Researchers Design Polymer Macromolecules As Gene ...
Gene therapy depends upon foreign DNA, even viruses, to deliver genes, therapeutic proteins or medicine to cells within the body. Many scientists are looking for better chaperones across the cell membrane. Virginia Tech researchers think polymer molecules can be created to do the job. (Sun, 17 Sep 2006 16:05:44 GMT)
Purdue dedicates computer science building
Purdue University dedicated a new computer science building on Friday, a 100,000-square-foot complex equipped with high-tech equipment that school officials said would push the boundaries of science. (Mon, 18 Sep 2006 02:46:19 GMT)
$100M cancer deal shines light on Arizona bio
Leading a $100 million pilot project to collect and analyze cancer tissue samples not only is putting the International Genomics Consortium on the map, but Arizona's burgeoning biotech industry as well. (Mon, 18 Sep 2006 04:35:58 GMT)
Dabur OncQuest receives NABL accreditation
Dabur OncQuest, a leader in Indian oncology medical testing market, has recently been accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) in accordance with ISO 15189:2003, which is specific to medical testing laboratories. (Mon, 18 Sep 2006 06:01:26 GMT)
University unveils plans for new era in chemistry
The University will break ground next fall on a sleek new chemistry building, pending approval by the regional planning board in the coming weeks. The new, cutting-edge building will be funded largely by royalties from the sale of Alimta, a potent cancer drug developed by chemistry professor emeritus Edward Taylor and patented by the University, President Tilghman wrote to alumni last year. (Mon, 18 Sep 2006 06:41:31 GMT)
Novel Biomarker For Prediction Of Survival In Colorectal Carcinomas Revealed
Levels of a protein called thymidylate synthase (TS) within two separate compartments of a tumor cell-the nucleus and the cytoplasm-may be critical markers predicting survival in colorectal cancer, according to a study at Yale University School of Medicine.The study revealed two different and independent predictors of survival in colorectal cancer. [click link for full article] (Mon, 18 Sep 2006 07:12:28 GMT)
Public Library Of Science To Launch New, Open Access Journal On Neglected Tropical Diseases
The Public Library of Science (PLoS) announced the creation of PLoS Neglected Tropical Diseases, the first open access journal devoted to the world's most neglected diseases.PLoS Neglected Tropical Diseases (http://www.plosntds. [click link for full article] (Mon, 18 Sep 2006 07:13:48 GMT)
New Insights Into The Cause Of Alzheimer's Disease - Possible Starting Points For Developing Causative Therapies
Scientists are gaining ever more insight into the causative mechanisms involved in Alzheimer's disease. [click link for full article] (Mon, 18 Sep 2006 07:15:09 GMT)
Vatican Believes in Pfizer Spinoff
A church group bought the firm, a specialist in experimental cancer treatments. (Mon, 18 Sep 2006 07:17:17 GMT)
Two Copies Of A Parkinson's Gene Mutation Doesn't Lead To More Severe Disease
Parkinson's disease researchers found no observable differences between those who have two copies of the most common mutation of the recently discovered LRRK2 gene and those who have only one copy. In most diseases with a genetic component, two copies of a bad gene lead to earlier or more severe symptoms. Researchers did not find that to be true in a group of individuals with two copies of the (Mon, 18 Sep 2006 10:04:23 GMT)
Electric Jolt Triggers Release Of Biomolecules, Nanoparticles
Researchers have devised a way to use a brief burst of electricity to release biomolecules and nanoparticles from a tiny gold launch pad. The technique could be used to dispense small amounts of medicine on command from a chip implanted in the body. (Mon, 18 Sep 2006 10:19:17 GMT)
Food technologists debate processing techniques in Nantes
18/09/2006 - Food technologists are meeting this week in Nantes, France, to debate the latest scientific discoveries in processing, health and safety. (Mon, 18 Sep 2006 10:51:21 GMT)
Affymetrix Signs First Translational Medicine Agreement in China
SANTA CLARA, Calif.----Sept. 18, 2006--Affymetrix Inc. and Zhejiang California Nanosystem Institute at Zhejiang University announced today that they have entered into a collaboration to develop clinical applications using GeneChip® technology. (Mon, 18 Sep 2006 12:00:00 GMT)
Clinical Data Named For Second Year in Row as One of New England's Fastest Growing Life Sciences Companies in
NEWTON, Mass.----Sept. 18, 2006--Clinical Data, Inc. has been named for the second year in a row to Deloitte's prestigious Technology Fast 50 Program for New England, a ranking of the 50 fastest growing technology, media, telecommunications and life sciences companies in the area by Deloitte & Touche USA LLP, one of the nation's leading professional services organizations. (Mon, 18 Sep 2006 12:01:00 GMT)
HTG Appoints William Radany CEO
TUCSON, Ariz.----Sept. 18, 2006--HTG, Inc., a provider of novel array-based gene expression assay technology and services for the life sciences industry, today announced the appointment of Dr. (Mon, 18 Sep 2006 13:00:00 GMT)
Accelerator speeds bioinformatics data processing.
BioBoost bioinformatics data processing accelerator for Mac OS X v10.4 Tiger provides hardware processing for computationally intensive applications. By utilizing field programmable gate array (FPGA) technology, processor is able to rewire itself on-the-fly according to application that needs to be accelerated, allowing single hardware accelerator to speed up any number of supported applications. (Mon, 18 Sep 2006 13:11:09 GMT)
NuGEN Launches Two New Products: The WT-Ovation(TM) Pico RNA Amplification System and the FL-Ovation(TM) cDNA Biotin
SAN CARLOS, Calif.----Sept. 18, 2006--NuGEN Technologies, Inc.: Built on NuGEN's proprietary Ribo-SPIA technology for gene expression analysis of small and challenging samples; enables amplification and microarray analysis across the entire transcriptome with picogram levels of total RNA (Mon, 18 Sep 2006 14:05:00 GMT)
Affy, Chinese University Pen Translational Genomics Alliance; Will Create Lab to Support GeneChip Research
If you have already registered, then login here . (To avoid this screen in the future, do not logout.) (Mon, 18 Sep 2006 14:05:51 GMT)
Nobel Prize winner to speak at Campbell
Dr. Richard J. Roberts, Nobel Prize winner for Medicine, will speak on Friday, Sept. 22, at 10:30 a.m. in Turner Auditorium of the D. Rich Memorial building. (Mon, 18 Sep 2006 15:17:49 GMT)
Single Molecular 'Mark' Seen As Pivotal For Genome Compaction In Spores And Sperm
In animals, genes are passed from parents to offspring via sperm or eggs. In some single-celled organisms, such as yeast, genes can be passed on in spores. In both strategies, the genomic material becomes dramatically compacted during the process, reduced in volume to as little as five percent of its original volume. A new study identifies a single molecule required for genome compaction and (Mon, 18 Sep 2006 16:04:08 GMT)
High-value Chemicals Produced From Ethanol Feedstocks Could Boost Biorefinery Economics
Biorefineries developed to produce ethanol from cellulose sources such as trees and fast-growing plants could get a significant economic boost from the sale of high-value chemicals -- such as vanillin flavoring -- that could be generated from the same feedstock. Revenue from these "side stream" chemicals could help make ethanol produced by biorefineries cost competitive with traditional fossil (Mon, 18 Sep 2006 16:04:29 GMT)
Food technologists debate processing techniques in Nantes
9/18/2006 - Food technologists are meeting this week in Nantes, France, to debate the latest scientific discoveries in processing, health and safety. (Mon, 18 Sep 2006 16:08:05 GMT)
HTG Appoints William Radany CEO
HTG, Inc., a provider of novel array-based gene expression assay technology and services for the life sciences industry, today announced the appointment of Dr. William Radany to the position of chief executive officer. (Mon, 18 Sep 2006 16:21:34 GMT)
IBC'S Newly Expanded Event, Discovery-2-Diagnostics, to Take Place in Boston Next Week
IBC's newly expanded event, Discovery-2-Diagnostics, focusing on maximizing microarrays, biomarkers and molecular diagnostics to scientifically advance new discoveries and novel technologies, will be taking place September 25-27 at the Hynes Convention Center in Boston. (Mon, 18 Sep 2006 17:32:00 GMT)
Evolutionary software to be released free of charge
CHAMPAIGN, Ill. -- New software developed by researchers at the University of Illinois at Urbana-Champaign allows scientists to more effectively analyze and compare both sequence and structure data from a growing library of proteins and nucleic acids. (Mon, 18 Sep 2006 17:39:20 GMT)
Molecular Devices Introduces FlexStation 3 Next-Generation System for Kinetic Cell-based Assays
SUNNYVALE, Calif., Sept. 18 /PRNewswire-FirstCall/ -- Molecular Devices Corporation ( Nachrichten ), a leader in innovative solutions for drug discovery and life sciences research, today introduced FlexStation(R) 3 next- generation multi-detection benchtop reader with fluidics. (Mon, 18 Sep 2006 18:25:13 GMT)
Molecular Devices Introduces StakMax Microplate Handling System for SpectraMax Microplate Readers
SUNNYVALE, Calif., Sept. 18 /PRNewswire-FirstCall/ -- Molecular Devices Corporation ( Nachrichten ), a leader in innovative solutions for drug discovery and life sciences research, today announced the introduction of StakMax(TM), an integrated microplate handling system for its SpectraMax(R) line of microplate readers. (Mon, 18 Sep 2006 18:25:23 GMT)
Third medical school clears major hurdle
Arizona's third medical school is on its way to becoming a reality. (Mon, 18 Sep 2006 18:45:52 GMT)
Evolutionary scientific software released
CHAMPAIGN, Ill., Sept. 18 (UPI) -- Software designed by U.S. scientists is allowing researchers to effectively analyze and compare sequence and structure data of proteins and nucleic acids. (Mon, 18 Sep 2006 18:59:25 GMT)
Nanonscience grant for UB
Researchers at the University at Buffalo will continue their research in medical imaging using nanoscience with help from a $1.1 million grant. (Mon, 18 Sep 2006 19:18:11 GMT)
Chr. Hansen and Integrated Genomics to Sequence a Probiotic Lactic Acid Bacterium
Integrated Genomics Inc., a leading provider of microbial gene sequencing and analysis services, has signed an agreement with Chr. Hansen A/S in Denmark to sequence, close, and annotate the genome of a probiotic lactic acid bacterium. (Mon, 18 Sep 2006 19:49:00 GMT)
Active Motif Launches AKS2 Literature Mining System
Active Motif, Inc. is pleased to announce the launch of its latest text mining system, AKS2 (almaKnowledgeServer(TM)) from bioalma. The newly-designed interface of AKS2 enables rapid exploration of not only disease, gene, and compound topics found in published literature but also drug, symptom, and biomedical relationships as well. (Mon, 18 Sep 2006 20:00:00 GMT)
IBC's Newly Expanded Event, Discovery-2-Diagnostics, to Take Place in Boston Next Week
IBC's newly expanded event, Discovery-2-Diagnostics, focusing on maximizing microarrays, biomarkers and molecular diagnostics to scientifically advance new discoveries and novel technologies, will be taking place September 25-27 at the Hynes Convention Center in Boston. (Mon, 18 Sep 2006 21:19:59 GMT)
Invitrogen to Present at 2006 UBS Global Life Science Conference
CARLSBAD, Calif.----Sept. 18, 2006--Invitrogen Corporation announced it will present at the 2006 UBS Global Life Science Conference on Tuesday, September 26, 2006 at 3:00 p.m. Eastern Time at the Grand Hyatt Hotel in New York City. (Mon, 18 Sep 2006 22:11:00 GMT)
Molecular Devices Introduces FlexStation 3 Next-Generation System for Kinetic Cell-based Assays
Molecular Devices Corporation , a leader in innovative solutions for drug discovery and life sciences research, today introduced FlexStation(R) 3 next- generation multi-detection benchtop reader with fluidics. FlexStation 3 is based on Molecular Devices' popular SpectraMax(R) M5 multi-detection system with the addition of liquid handling. The system was developed for use in research, assay (Mon, 18 Sep 2006 22:45:48 GMT)
Molecular Devices Introduces StakMax Microplate Handling System for SpectraMax Microplate Readers
Molecular Devices Corporation , a leader in innovative solutions for drug discovery and life sciences research, today announced the introduction of StakMax(TM), an integrated microplate handling system for its SpectraMax(R) line of microplate readers. The StakMax system enables researchers to run batches of microplates, which increases productivity by requiring less hands- on time during (Mon, 18 Sep 2006 22:46:01 GMT)
Chr. Hansen and Integrated Genomics to Sequence a Probiotic Lactic Acid Bacterium
Integrated Genomics Inc., a leading provider of microbial gene sequencing and analysis services, has signed an agreement with Chr. Hansen A/S in Denmark to sequence, close, and annotate the genome of a probiotic lactic acid bacterium. This contract continues a multiyear relationship between the companies in lactic acid microbial genomics. Scientists at Chr. Hansen's Genomics & Strain Development (Tue, 19 Sep 2006 00:00:48 GMT)
Active Motif Launches AKS2 Literature Mining System
Active Motif, Inc. is pleased to announce the launch of its latest text mining system, AKS2 (almaKnowledgeServer(TM)) from bioalma. (Tue, 19 Sep 2006 01:10:12 GMT)
Dabur OncQuest Receives NABL Accreditation
Dabur OncQuest, an offshoot of Dabur Pharma, which concentrates on Indian oncology medical testing market, has received National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation. (Tue, 19 Sep 2006 02:46:03 GMT)
Two Years Research Project Into RNAi Mediated Regulatory Networks
Genomatix Software GmbH of Munich, Germany, has won a "BioChance" research contract from the German Federal Ministry of Education and Research to pursue research in RNAi mediated regulatory networks and to further expand its competence and product line into this exciting new field. The project is scheduled to run for two years and is worth more than US$ 1.6 million. [click link for full article] (Tue, 19 Sep 2006 03:10:07 GMT)
Outsourcing Trends Combined With Holistic Systems Biology-Based Approach to Define Future of European Bioinformatics
Bioinformatics will increasingly become a necessity for a wide spectrum of life sciences, pharmaceutical and biotechnology companies. As the number of market participants increases, purchasers will have an edge as the range of available tools expands. (Tue, 19 Sep 2006 07:00:00 GMT)
Solexa to Present at the UBS Global Life Sciences Conference
Solexa, Inc. (9645;Nasdaq:SLXA) today announced that it will present at the UBS Global Life Sciences Conference (Tue, 19 Sep 2006 07:14:24 GMT)
BioDiscovery Releases ImaGene 7 Microarray Image Analysis Software and Associated New aCGH Module
BioDiscovery Inc., the leading developer of integrated software solutions for microarray research, announced today the release of ImaGene 7 microarray image analysis software, featuring an integrated interactive array-based Comparative Genomic Hybridization (CGH) analysis module. (PRWEB Sep 19, 2006) Trackback URI: http://www.prweb.com/zingpr.php/U2luZy1aZXRhLVNxdWEtSG9yci1JbnNlLVplcm8= (Tue, 19 Sep 2006 07:20:50 GMT)
Luminex and Exiqon Announce Development and Commercialization Agreement
Luminex® Corporation , a leading multiplex solution developer, and Exiqon A/S, a leading supplier of high-value gene expression analysis products, announced today the signing of an agreement to co-develop and commercialize microRNA products. (Tue, 19 Sep 2006 10:00:00 GMT)
Genome Explorations Joins CombiMatrix CombiCore(TM) Access Program
NEWPORT BEACH, Calif.----Sept. 19, 2006--Acacia Research Corporation announced today that its CombiMatrix group has signed a non-exclusive agreement with Genome Explorations of Memphis, Tennessee, under the company's CombiCore access program. (Tue, 19 Sep 2006 10:00:00 GMT)
RIT looking for right fit at the top — no easy task
Rochester Institute of Technology is hunting for a new president. The area's largest four-year higher education institution expects to have its next chief executive hired by late March. (Tue, 19 Sep 2006 10:01:03 GMT)
Santa Cruz makes move to check growth at UC
When UC-Santa Cruz opened in 1965, it roused a sleepy little coastal burg filled with longtime residents, surfers and retirees. Formed as a cluster of colleges where students shared dorms and meals with professors, the school was hailed as an antidote to giant research-driven campuses. (Tue, 19 Sep 2006 10:16:58 GMT)
Stratagene to Present at the UBS Global Life Sciences Conference
LA JOLLA, Calif.----Sept. 19, 2006--Stratagene Corporation today announced that it will present at the UBS Global Life Sciences Conference, which will take place at the Grand Hyatt Hotel in New York City, on Tuesday, September 26, 2006. (Tue, 19 Sep 2006 10:30:00 GMT)
Celera Genomics to Webcast Presentation at the UBS Global Life Sciences Conference
ROCKVILLE, Md.----Sept. 19, 2006--The Celera Genomics Group , an Applera Corporation business, will webcast its presentation at the UBS Global Life Sciences Conference on Tuesday, September 26, 2006. (Tue, 19 Sep 2006 11:00:00 GMT)
DNAPrint Genomics Receives Patent for Identifying Links Between Gene Sequences and Medical Traits
DNAPrint Genomics, Inc. today announced that the Company has formally been granted a patent by the U.S. Patent and Trademark Office for Methods for the Identification of Genetic Features for Complex Genetics Classifiers. (Tue, 19 Sep 2006 11:00:00 GMT)
Applied Biosystems to Webcast Presentation at UBS Global Life Sciences Conference
FOSTER CITY, Calif.----Sept. 19, 2006--Applied Biosystems Group , an Applera Corporation business, will webcast its presentation at the UBS Global Life Sciences Conference on Wednesday, September 27, 2006. (Tue, 19 Sep 2006 11:00:00 GMT)
Nanocantilever biosensors detect multiple genes
Using nanoscale cantilevers in a microfluidics device, a team of European researchers has developed a portable biosensor capable of detecting specific genetic sequences. (Tue, 19 Sep 2006 11:00:54 GMT)
Acacia's CombiMatrix Signs New Provider
Acacia Research Corp. said Tuesday that Memphis-based Genome Explorations has signed on as a service provider for the company's CombiCore access program. (Tue, 19 Sep 2006 11:03:31 GMT)
Acacia\'s CombiMatrix signs new provider
Genome Explorations provides academic and industrial institutes with gene expression profiling services. Under the terms of the agreement, Genome Explorations is certified as an authorized service provider for CombiMatrix CustomArray and CatalogArray products. (Tue, 19 Sep 2006 11:14:01 GMT)
Acacia's CombiMatrix Signs New Provider
(AP) NEWPORT BEACH, Calif. Acacia Research Corp. said Tuesday that Memphis-based Genome Explorations has signed on as a service provider for the company's CombiCore access program. (Tue, 19 Sep 2006 11:20:16 GMT)
Washington State University Extends MetaCore Licenses From GeneGo
GeneGo, Inc., a leading provider of software and databases for systems biology, today announced that Washington State University Tri-cities has extended their license of MetaCore. MetaCore's new release 4.0 has unique features that give researchers a multi-level analysis of experimental data with respect to functional processes, diseases and consensus pathways in just one click. (Tue, 19 Sep 2006 12:00:00 GMT)
BioDiscovery Releases ImaGene 7 Microarray Image Analysis Software and Associated New aCGH Module
El Segundo, CA (PRWEB) September 19, 2006 -- BioDiscovery Inc. (Tue, 19 Sep 2006 12:00:00 GMT)
GC/MS System comes in 3 pump configurations.
With scan speeds greater than 11,000 amu/sec, Model DSQ II Single Quadrupole GC/MS System features mixed scan mode capabilities for sequential selected ion monitoring and full scan analysis. It incorporates DynaMax XR ion detection system that allows for linear quantitation across 6 orders of magnitude and DuraBrite(TM) ion source that has source designs to increase robustness with heavy matrix (Tue, 19 Sep 2006 12:46:31 GMT)
New CLSI Guideline Provides Protocols for the Use of RNA Controls in Gene Expression Assays
WAYNE, Pa.----Sept. 19, 2006--Microarray and QRT-PCR technologies are emerging as vital components of genomic, evidence-based medicine. Standard controls are required to ensure reliability and quality from these assay platforms before microarray and QRT-PCR results are accepted for clinical applications. (Tue, 19 Sep 2006 14:00:00 GMT)
Luminex and Exiqon Announce Development and Commercialization Agreement
Luminex(R) Corporation (Nasdaq: LMNX), a leading multiplex solution developer, and Exiqon A/S, a leading supplier of high-value gene expression analysis products, announced today the signing of an agreement to co-develop and commercialize microRNA products. (Tue, 19 Sep 2006 14:01:29 GMT)
Luminex and Exiqon Announce Development and Commercialization Agreement
Luminex(R) Corporation , a leading multiplex solution developer, and Exiqon A/S, a leading supplier of high-value gene expression analysis products, announced today the signing of an agreement to co-develop and commercialize microRNA products. Exiqon will develop and manufacture microRNA products on behalf of the Luminex Bioscience Group (LBG) based on Luminex's xMAP(R) technology and Exiqon's (Tue, 19 Sep 2006 14:02:22 GMT)
£14.9 million award to MRC Protein Phosphorylation Unit
The Medical Research Council Protein Phosphorylation Unit at the University of Dundee has had its funding for the next five years almost doubled to £14.9 million after an overwhelmingly positive review of its activities. (Tue, 19 Sep 2006 14:08:06 GMT)
Bio-IT Briefs
September 19, 2006 | Sigma-Aldrich is adding The Wistar Institute, Mayo Clinic, Tufts University, Princeton University, the Moores Cancer Center at the University of California, San Diego (UCSD), and Washington University in St. Louis to the Sigma RNAi Partnership Program . Sigma-Aldrich established the RNAi Partnership Program to advance functional genomics research by providing tools for RNA (Tue, 19 Sep 2006 14:20:44 GMT)
QIAGEN to Present at the UBS Global Life Sciences Conference
QIAGEN N.V. today announced that it will present at the 2006 UBS Global Life Sciences Conference at 10:30 a.m. EDT on Tuesday, September 26, 2006. The conference is being held at The Grand Hyatt, Park Avenue at Grand Central Station, New York City. (Tue, 19 Sep 2006 14:56:00 GMT)
DNAPrint Genomics Receives Patent for Identifying Links Between Gene Sequences and Medical Traits
DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced that the Company has formally been granted a patent by the U.S. Patent and Trademark Office for Methods for the Identification of Genetic Features for Complex Genetics Classifiers. (Tue, 19 Sep 2006 15:21:20 GMT)
Muscle Cells Self-destruct Rather Than Grow With Use
Muscle cells that should grow stronger with use instead self-destruct when a protein called BAG3 isn't around, researchers have shown. (Tue, 19 Sep 2006 15:51:19 GMT)
'Stretched' Stem Cells Have Potential To Be Transformed Into Blood Vessel Cells
Scientists have searched for years for a renewable cell source to craft blood vessels that can be used for heart bypass surgery and perform more like natural arteries. Now, researchers at the University of California, Berkeley, have shown that mesenchymal stem cells from adult bone marrow can be repeatedly and mechanically stretched -- in a manner similar to a taffy pull -- into patterns. (Tue, 19 Sep 2006 15:52:09 GMT)
Genome-management System Seen As A Natural Protection Against Cancer
The human genome keeps selected genes readily available for use while other genes are kept securely stored away for long periods of time, sometimes forever. Candidate genes for such long-term storage include those required only for early development and proliferation, potentially dangerous genes that could well trigger cancers if reactivated later in life. In a new study, researchers have (Tue, 19 Sep 2006 15:52:29 GMT)
Molecular Devices Announces Webcast of Presentation at UBS Global Life Sciences Conference
Molecular Devices Corporation , a leader in innovative solutions for drug discovery and life sciences research, today announced that Joseph D. Keegan, Ph.D., CEO and President, will present at the UBS Global Life Sciences Conference on Wednesday, September 27, 2006 at 2:00 PM at the Grand Hyatt Hotel in New York City. (Tue, 19 Sep 2006 16:07:00 GMT)
UT Southwestern scientist receives NIH Director's Pioneer Award
DALLAS – Sept. 19, 2006 -- Dr. Thomas Kodadek, chief of the Division of Translational Research at UT Southwestern Medical Center, has won a National Institutes of Health Director's Pioneer Award, designed to support scientists of "exceptional creativity." (Tue, 19 Sep 2006 16:23:46 GMT)
Denmark's Chr. Hansen, Integrated Genomics to Sequence Probiotic Lactic Acid Bacterium
If you have already registered, then login here . (To avoid this screen in the future, do not logout.) (Tue, 19 Sep 2006 18:36:10 GMT)
Caprion Announces Completion of Phase I Clinical Studies for its Shigatoxin-producing E. coli Therapy
MONTREAL----Sept. 19, 2006--Caprion Pharmaceuticals Inc. announced today the completion of Phase I studies for Shigamabs®, its therapeutic product currently in human clinical trials for the treatment of Shigatoxin-producing E. coli infections. (Tue, 19 Sep 2006 18:43:00 GMT)
Caprion Announces Completion of Phase I Clinical Studies for Its Shigatoxin-Producing E. Coli Therapy
Caprion Pharmaceuticals Inc. announced today the completion of Phase I studies for Shigamabs(R), its therapeutic product currently in human clinical trials for the treatment of Shigatoxin-producing E. coli infections. Infections by Shigatoxin-producing E. (Tue, 19 Sep 2006 21:28:15 GMT)
Galapagos raises EUR 11.1 million from new equity issue
Galapagos NV (Euronext & LSE:GLPG) has placed 1,305,074 new shares in a successful privateplacement with Fortis Bank NV, at a price of EUR 8.50 per share. Fortisintends to place these new shares with international institutionalclients via an accelerated bookbuilding procedure. Galapagos raisedgross proceeds of EUR 11.1 million. (Tue, 19 Sep 2006 23:29:38 GMT)
Teva and Procognia (Israel) Ltd. Sign an Exclusive Collaboration Agreement for the Development Of Biopharmaceuticals
JERUSALEM & ASHDOD, Israel----Sept. 20, 2006--Teva Pharmaceutical Industries Ltd. and Procognia Ltd. announced today that they had entered into a collaboration agreement covering two biopharmaceuticals, for which Procognia Ltd. will supply Teva services and access to its proprietary glycoanalysis technology on an exclusive basis. (Wed, 20 Sep 2006 04:01:00 GMT)
ExonHit Therapeutics - First Half 2006 Results
ExonHit Therapeutics S.A. , a French drug and diagnostic discovery company, today announces its consolidated financial results for first half 2006. (Wed, 20 Sep 2006 06:00:00 GMT)
Teva and Procognia (Israel) Ltd. Sign an Exclusive Collaboration Agreement for the Development Of Biopharmaceuticals
Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) and Procognia (Israel) Ltd. announced today that they had entered into a collaboration agreement covering two biopharmaceuticals, for which Procognia (Israel) Ltd. (Wed, 20 Sep 2006 06:11:51 GMT)
IBS to set up research and product development facility in India
Mumbai, Sep 20: British sofware solutions provider Intelligent Business Systems plans to set up a research and product development centre in India to leverage the growth potential in the world's fastest growing technology market. (Wed, 20 Sep 2006 09:30:20 GMT)
IBS plans R & D unit in India
British sofware solutions provider Intelligent Business Systems plans to set up a research and product development centre in India to leverage the growth potential in the world's fastest growing technology market. (Wed, 20 Sep 2006 10:10:27 GMT)
Researchers identify regulator and associated signalling cascade in human immunlogical disorder
GNI Ltd, a leading biopharmaceutical company in Asia, and its Chinese affiliate Shanghai Genomics, announced that their researchers had identified an important regulator and its associated signalling cascade in X-linked lymphoproliferative disease (XLP), a human immunological disorder. (Wed, 20 Sep 2006 11:00:56 GMT)
Wednesday, September 20th Stock Trading Alert
eLocity's stocks to watch for today are: DC Brands International, Inc., Unico, Inc., DNAPrint Genomics, Inc., and China Direct Trading Corp. (OTC.BB: CHDT). (Wed, 20 Sep 2006 11:10:00 GMT)
Acacia Technologies Acquires Rights to Patent for Vehicle Magnetic Braking and Motor Technology
NEWPORT BEACH, Calif., BUSINESS WIRE -- Acacia Research Corporation (Nasdaq:ACTG) (Nasdaq:CBMX) announced today that Acacia Patent Acquisition Corporation, a wholly owned subsidiary that is part of the Acacia Technologies group, a leader in technology licensing, has acquired rights to patents relating to vehicle magnetic braking and induction motors. (Wed, 20 Sep 2006 11:30:35 GMT)
Arbor Vita Receives Phase II SBIR to Commercialize Cervical Cancer Diagnostic
Arbor Vita Corporation, a biotechnology company, today announced that the National Institutes of Health has awarded Arbor Vita approximately $900,000 to develop and commercialize an in vitro diagnostic test for cervical pre-cancer and cancer. (Wed, 20 Sep 2006 12:00:00 GMT)
Illumina to Webcast Presentation at UBS Global Life Sciences Conference
Illumina, Inc. (NASDAQ:ILMN) announced today that Jay Flatley, President and CEO, will present an overview of the Company's commercial and product development activity at the upcoming UBS Global Life Sciences Conference in New York, New York (USA). Mr. (Wed, 20 Sep 2006 12:16:41 GMT)
Affymetrix to Webcast Presentation at UBS Global Life Sciences Conference
SANTA CLARA, Calif.----Sept. 20, 2006--Affymetrix, Inc. today announced it will webcast its presentation from the UBS Global Life Sciences Conference in New York City. Greg Schiffman, Executive Vice President and Chief Financial Officer, will provide a company update and financial details on the previously announced corporate restructuring at 1:30 p.m. (Wed, 20 Sep 2006 13:00:00 GMT)
Miraculins to Present Study Results at Major Gastroenterology Conference
Miraculins Inc., a biotechnology company, dedicated to the discovery and validation of cancer biomarkers for use in developing diagnostic tools and therapeutic products, is pleased to announce that it will be presenting results from the recent verification study for its colorectal cancer diagnostic at the Annual American College of Gastroenterology Scientific Meeting being held in Las Vegas, Oct (Wed, 20 Sep 2006 13:03:00 GMT)
Miraculins to Present Study Results at Major Gastroenterology Conference
WINNIPEG, MANITOBA-- - Miraculins Inc. , a biotechnology company, dedicated to the discovery and validation of cancer biomarkers for use in developing diagnostic tools and therapeutic products, is pleased to announce that it will be presenting results from the recent verification study for its colorectal cancer diagnostic at the Annual American College of Gastroenterology Scientific Meeting (Wed, 20 Sep 2006 13:03:06 GMT)
Acacia Technologies Acquires Rights to Patent for Vehicle Magnetic Braking and Motor Technology
NEWPORT BEACH, Calif.--Sept. 20, 2006--Acacia Research Corporation announced today that Acacia Patent Acquisition Corporation, a wholly owned subsidiary that is part of the Acacia Technologies group, a leader in technology licensing, has acquired rights to patents relating to vehicle magnetic braking and induction motors. (Wed, 20 Sep 2006 13:20:55 GMT)
Biosite Incorporated to Host 3rd Annual Investor R&D Day Conference
Biosite Incorporated will host its 3rd Annual Investor R&D Day Conference: Establishing Excellence in Diagnostic Innovation, on Tuesday, October 3, 2006, beginning at 9:00 AM Eastern Daylight Time. (Wed, 20 Sep 2006 13:29:00 GMT)
Power3 Medical Products Files Utility Patent Application on Discovery that Distinguishes Between Parkinson's and ALS
HOUSTON----Sept. 20, 2006--Power3 Medical Products, Inc. , announced today that it has filed for a utility patent that encompasses multiple blood serum protein biomarkers useful in distinguishing patients with Parkinson's disease and ALS . (Wed, 20 Sep 2006 13:59:00 GMT)
GNI Identifies Important Reuglator and Associated Signaling Cascade in Human Immunological Disorders
Tokyo, Sept 20, 2006 (JCN) - GNI and its Chinese affiliate Shanghai Genomics announced September 15 that they have identified an important regulator and its associated signaling cascade in X-linked lymphoproliferative disease (XLP), a human immunological disorder. (Wed, 20 Sep 2006 14:27:35 GMT)
Gene Expression: New CLSI Guideline Provides Protocols For The Use Of RNA Controls In Gene Expression Assays
Microarray and QRT-PCR technologies are emerging as vital components of genomic, evidence-based medicine. Standard controls are required to ensure reliability and quality from these assay platforms before microarray and QRT-PCR results are accepted for clinical applications (Wed, 20 Sep 2006 14:35:04 GMT)
DNA technology identified as alternative to visual identification of wheat varieties
"A Montreal based genomics firm is confident DNA technology holds the key to determining wheat variety without the need for visual identification. (Wed, 20 Sep 2006 15:00:23 GMT)
IBS to set up R&D facility in India
British software solutions provider Intelligent Business Systems plans to set up a research and product development centre in India to leverage the growth potential in the world's fastest growing technology market. (Wed, 20 Sep 2006 15:03:57 GMT)
Arbor Vita Receives Phase II SBIR to Commercialize Cervical Cancer Diagnostic
SUNNYVALE, Calif., Sept. 20 /PRNewswire/ -- Arbor Vita Corporation, a biotechnology company, today announced that the National Institutes of Health (NIH) has awarded Arbor Vita approximately $900,000 to develop and commercialize an in vitro diagnostic test for cervical pre-cancer and cancer. (Wed, 20 Sep 2006 15:17:27 GMT)
HHMI Hosts International Biomedical Scientists
Top biomedical scientists from 28 countries will gather at the new Janelia Farm Research Campus of the Howard Hughes Medical Institute (HHMI) to share data from their latest research into some of the world's toughest medical challenges, such as TB, malaria, and antibiotic resistance. (Wed, 20 Sep 2006 16:24:56 GMT)
Miraculins to Present Study Results at Major Gastroenterology Conference
Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company, dedicated to the discovery and validation of cancer biomarkers for use in developing diagnostic tools and therapeutic products, is pleased to announce that it will be presenting results from the recent verification study for its colorectal cancer diagnostic at the Annual American College of Gastroenterology Scientific Meeting being held (Wed, 20 Sep 2006 17:31:28 GMT)
Clinical Data to Discuss MicroArray Quality Control (MAQC) Project Results at Discovery-2-Diagnostics Conference
NEWTON, Mass.----Sept. 20, 2006--Clinical Data Inc. , a worldwide leader in providing comprehensive molecular biology and pharmacogenomics services as well as clinical diagnostics to improve patient care, announced today that its Cogenics division will discuss its integral role in the MicroArray Quality Control project for generating and analyzing multi-platform gene expression data at Booth # (Wed, 20 Sep 2006 19:32:00 GMT)
HHMI Hosts International Scientists at Janelia Farm Research Campus
Top biomedical scientists from 28 countries will gather at the new Janelia Farm Research Campus of the Howard Hughes Medical Institute (HHMI) to share insights and data from their latest research on some of the world's toughest medical challenges—such as tuberculosis, malaria, and antibiotic resistance. (Wed, 20 Sep 2006 20:02:44 GMT)
Clinical Data to Discuss MicroArray Quality Control (MAQC) Project Results at Discovery-2-Diagnostics Conference
FDA Scientist Keynote Panel Presentation on MAQC Project Results from Initiative Assessing Reproducibility of Microarray Data Clinical Data Inc. (Wed, 20 Sep 2006 20:12:12 GMT)
Fruit Fly Aggression Study Has Human, Animal Relevance
Researchers in the North Carolina Sate University genetics department have identified a suite of genes that affect aggression in the fruit fly Drosophila melanogaster, pointing to new mechanisms that could contribute to abnormal aggression in humans and other animals. (Wed, 20 Sep 2006 20:25:13 GMT)
Fruit Fly Aggression Study Has Human, Animal Relevance
Even the tiny, mild-mannered fruit fly can be a little mean sometimes - especially when there`s a choice bit of rotten fruit to fight over. And, like people, some flies have shorter tempers than others. (Wed, 20 Sep 2006 20:33:34 GMT)
Hot Topics & News Tips: Friday, September 29, 2006
Research to be presented at the HHMI 2006 International Scholars Meeting, 29-Sep: 1) Winning the War Against Malaria -- Treatments; 2) Winning the War Against Malaria -- Vaccines; 3) Bugs, Drugs, and Microarrays; 4) Starving Flesh-eating Bacteria; 5) Love Songs of the Sand Fly Siblings. (Wed, 20 Sep 2006 21:25:42 GMT)
How small IT firms are wooing clients
Marketing initiatives are either being strengthened or being innovated upon to grab a toehold in the global IT market. (Thu, 21 Sep 2006 04:40:27 GMT)
Arbor Vita Receives Phase II SBIR To Commercialize Cervical Cancer Diagnostic
Arbor Vita Corporation, a biotechnology company, today announced that the National Institutes of Health (NIH) has awarded Arbor Vita approximately $900,000 to develop and commercialize an in vitro diagnostic test for cervical pre-cancer and cancer. The Phase II Small Business Innovation Research (SBIR) grant will fund the company's test based on detection of the HPV-E6 oncoprotein. [click link (Thu, 21 Sep 2006 07:13:09 GMT)
DNAPrint gets patent for test
SARASOTA -- DNAPrint Genomics Inc. has been granted a patent for its "Methods for the Identification of Genetic Features for Complex Genetics Classifiers." (Thu, 21 Sep 2006 08:32:04 GMT)
Illumina Introduces RatRef-12 Whole-Genome Expression BeadChip
SAN DIEGO----Sept. 21, 2006--Illumina, Inc. announced today that it has begun taking orders for a new whole-genome expression product for rat that analyzes twelve samples in parallel on a single BeadChip. (Thu, 21 Sep 2006 10:00:00 GMT)
Profile: Sir Christopher Evans
Sir Christopher Evans, the biotechnology venture capitalist and entrepreneur sometimes known as the 'biotech king', has a colourful reputation, write Lydia Adetunji and Andrew Jack. (Thu, 21 Sep 2006 10:20:30 GMT)
Invitrogen "buy"
NEW YORK, September 21 (newratings.com) - Analysts at Banc of America Securities maintain their "buy" rating on Invitrogen Corporation ( IVGN.NAS ). The target price is set to $70. (Thu, 21 Sep 2006 10:40:37 GMT)
DNAPrint Genomics Researcher to Lecture at Homicide Investigators Training Seminar
DNAPrint Genomics, Inc. announced today that Matt Thomas, Ph.D., Senior Scientist and Manager of Laboratory Operations for the Company, will be a scheduled guest lecturer at a seminar that will be part of the annual Mid-States Homicide Investigators Association Conference, to be held October 11 through 13, 2006, at the Hotel at Old Town in Wichita, Kan. (Thu, 21 Sep 2006 11:00:00 GMT)
Advances in Genetic Analysis Technology Aid Wild Salmon Conservation and Species Management
ANCHORAGE, Alaska & FOSTER CITY, Calif.----Sept. 21, 2006--Today in Anchorage, Alaska, international researchers will convene to discuss the use of the latest advances in genetic analysis technology to address the conservation and management of wild salmon in the Pacific Ocean. (Thu, 21 Sep 2006 11:00:00 GMT)
Toyobo, RIKEN Launch Photo-linker Chip for Making Low-Molecular Microarray
Tokyo, Sept 21, 2006 (JCN) - Toyobo Co., Ltd. (Toyobo) and RIKEN have collaborated on the launch of Photo-linker Chip in developing low-molecular microarray, which does not rely on the conventional method of functional groups. (Thu, 21 Sep 2006 11:12:35 GMT)
Accelr8 Announces Patent on Coatings for Patient Specimen Collection and Analytical Devices
DENVER, Sept. 21 /PRNewswire-FirstCall/ -- Accelr8 Technology Corp. has been awarded U.S. Patent 7,067,194 for devices that use its OptiChem(R) surface chemistry, including those for patient specimen collection and analytical products. (Thu, 21 Sep 2006 11:13:49 GMT)
Norgen Biotek Corp. Launches A Novel Line of Kits for the Removal of Endotoxins From DNA, Peptides and Proteins
Norgen Biotek, a product-focused and innovative Canadian biotechnology company dedicated to the development of powerful tools for nucleic acid and protein sample preparation, today announced the expansion of its nucleic acid and protein purification and clean up products by launching four new kits: the Endotoxin Removal Kits for DNA and the ProteoSpin Endotoxin Removal Kits for proteins and (Thu, 21 Sep 2006 13:00:00 GMT)
Mouse Colon Takes Top Honors at Nikon's Small World
Nikon's Small World winning image emerges from blackness to reveal the delicate, blue pebbly texture of the cell nuclei of a mouse colon as seen through the microscope. This winning image is the work of Dr. (Thu, 21 Sep 2006 14:11:00 GMT)
The Starr Foundation launches multi-institutional cancer consortium
New York, N.Y., Sept. 21, 2006 – The Starr Foundation today announced that it has made a $100 million grant to create a wide-ranging cancer consortium to coordinate the efforts of five internationally renowned research institutions in the fight against cancer. (Thu, 21 Sep 2006 14:43:36 GMT)
DNAPrint Genomics Researcher to Lecture at Homicide Investigators Training Seminar
DNAPrint Genomics, Inc. (OTCBB: DNAG) announced (Thu, 21 Sep 2006 15:14:12 GMT)
Arbor Vita Receives Grant for Cervical Cancer Test
The US National Institutes of Health has awarded Arbor Vita approximately $900,000 to develop and commercialize an in vitro diagnostic test for cervical pre-cancer and cancer. (Thu, 21 Sep 2006 15:14:22 GMT)
DNAPrint Genomics Researcher to Lecture at Homicide Investigators Training Seminar
DNAPrint Genomics, Inc. (OTCBB: DNAG) announcedtoday that Matt Thomas, Ph.D., Senior Scientist and Manager of LaboratoryOperations for the Company, will be a scheduled guest lecturer at a seminarthat will be part of the annual Mid-States Homicide InvestigatorsAssociation Conference, to be held October 11 through 13, 2006, at theHotel at Old Town in Wichita, Kan. (Thu, 21 Sep 2006 15:15:48 GMT)
Gene Network Sciences: Revolution 2.0
September 21, 2006 | In 2000, a cadre of young physicists from Cornell, led by CEO Colin Hill and Iya Khalil, funded by angel investors and government grants, picked up the mechanistic modeling mantra and produced a remarkable computational model of the colon cancer cell. (Thu, 21 Sep 2006 15:19:54 GMT)
Hundreds experience all Dalai Lama visit had to offer
As clouds from overnight rains scattered outside the Center for the Arts the morning of His Holiness the 14th Dalai Lama's Distinguished Speakers Series lecture at UB, early birds to campus on Tuesday cleared the mist from their own minds during an 8 a.m. meditation session in the Drama Theatre. (Thu, 21 Sep 2006 15:34:08 GMT)
Expression Analysis, Inc. Hires Quality Assurance Director
DURHAM, N.C.----Sept. 21, 2006--Expression Analysis , a full-service microarray testing, analysis and data management organization, has hired Raisa Lowe as Director of Quality Assurance. (Thu, 21 Sep 2006 15:46:00 GMT)
Previous 1 2 3 4 5 Next
